Published in Gastroenterology on November 01, 1990
19 Versus 22-Gauge Needle for EUS-LB (EUSLB1922) | NCT02967991
Development of a Breath Test for Monitoring Patients With Liver Disease | NCT00244569
Comparison of 19g FNA and 19g FNB Needles for EUS-LB | NCT03408171
Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology. Gut (1999) 3.10
Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol (2010) 2.96
Liver biopsy: blind or guided? BMJ (1994) 2.86
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol (2006) 1.86
Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg (2010) 1.81
Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology (2011) 1.80
Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut (2006) 1.61
Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. World J Gastroenterol (2007) 1.50
Hepatobiliary function assessed by 99mTc-mebrofenin cholescintigraphy in the evaluation of severity of steatosis in a rat model. Eur J Nucl Med Mol Imaging (2006) 1.50
Steatosis as a risk factor in liver surgery. Ann Surg (2007) 1.48
Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol (2006) 1.47
Thrombocytopenia is more severe in patients with advanced chronic hepatitis C than B with the same grade of liver stiffness and splenomegaly. J Gastroenterol (2010) 1.43
Performance of the AST-to-platelet ratio index as a noninvasive marker of fibrosis in pediatric patients with chronic viral hepatitis. J Pediatr Gastroenterol Nutr (2010) 1.35
New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol (2006) 1.17
Complications of percutaneous liver biopsy with Klatskin needles: a 36-year single-centre experience. Aliment Pharmacol Ther (2017) 1.14
Why, who and how should perform liver biopsy in chronic liver diseases. World J Gastroenterol (2008) 1.13
Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial. Hepatology (2012) 1.12
Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index. Dig Dis Sci (2003) 1.08
Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B. PLoS One (2012) 1.08
Staging of hepatic fibrosis: comparison of magnetic resonance elastography and shear wave elastography in the same individuals. Korean J Radiol (2013) 1.05
A diagnostic paradigm for resectable liver lesions: to biopsy or not to biopsy? HPB (Oxford) (2009) 1.05
Percutaneous liver biopsy complicated by hemobilia-associated acute cholecystitis. World J Gastroenterol (2006) 1.04
Transjugular liver biopsy in 52 patients with an automated Trucut-type needle. Dig Dis Sci (1999) 1.03
Transient elastography: Kill two birds with one stone? World J Hepatol (2013) 1.03
Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives. World J Gastroenterol (2013) 1.02
Safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures. Hepat Mon (2012) 1.00
Liver biopsy in modern clinical practice: a pediatric point-of-view. Adv Anat Pathol (2012) 0.98
Fatal haemorrhage following liver biopsy in patients with HIV infection. Genitourin Med (1996) 0.98
Aspartate aminotransferase to platelet ratio index correlates with hepatic cirrhosis but not with fibrosis in pediatric patients with intestinal failure. J Pediatr Gastroenterol Nutr (2013) 0.97
Liver biopsy for histological assessment: The case against. Saudi J Gastroenterol (2010) 0.94
Twelve potential fibrosis markers to differentiate mild liver fibrosis from cirrhosis in patients infected with chronic hepatitis C genotype 1. Eur J Clin Microbiol Infect Dis (2011) 0.93
Predictors of pain medication use after percutaneous liver biopsy. Dig Dis Sci (2002) 0.92
Comparison of FIB-4 and APRI in HIV-HCV coinfected patients with normal and elevated ALT. Dig Dis Sci (2011) 0.92
Liver biopsies for chronic hepatitis C: should nonultrasound-guided biopsies be abandoned? Can J Gastroenterol (2009) 0.92
Update of liver fibrosis and steatosis with transient elastography (Fibroscan). Gastroenterol Rep (Oxf) (2013) 0.90
Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C. World J Gastroenterol (2007) 0.90
Genomics and proteomics in liver fibrosis and cirrhosis. Fibrogenesis Tissue Repair (2012) 0.90
Percutaneous ultrasonographically guided liver punctures: an analysis of 1961 patients over a period of ten years. BMC Gastroenterol (2012) 0.87
Noninvasive assessment of hepatic fibrosis in patients with chronic hepatitis B viral infection using magnetic resonance elastography. Korean J Radiol (2014) 0.86
Non-invasive diagnosis of alcoholic liver disease. World J Gastroenterol (2014) 0.86
Fulminant sepsis after liver biopsy: A long forgotten complication? World J Clin Cases (2013) 0.86
Percutaneous liver biopsy: what is the current approach? Results of a questionnaire survey. Dig Dis Sci (2001) 0.85
Comparison of a new aspiration needle device and the Quick-Core biopsy needle for transjugular liver biopsy. World J Gastroenterol (2006) 0.85
Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha. World J Gastroenterol (2006) 0.84
Major hemorrhage after percutaneous liver biopsy in patients with AIDS. Gastroenterology (1991) 0.84
Checkmate to liver biopsy in chronic hepatitis C? World J Gastroenterol (2012) 0.84
Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study. Eur J Clin Microbiol Infect Dis (2013) 0.82
Value of liver biopsy prior to interferon therapy for chronic viral hepatitis. Dig Dis Sci (1998) 0.81
Endoscopic ultrasound-guided liver biopsy. Endosc Ultrasound (2015) 0.81
Venous thromboembolism in cirrhosis. Clin Appl Thromb Hemost (2012) 0.80
Gallbladder polyp as a manifestation of hemobilia caused by arterial-portal fistula after percutaneous liver biopsy: a case report. World J Gastroenterol (2005) 0.80
Outpatient blind percutaneous liver biopsy in infants and children: is it safe? Saudi J Gastroenterol (2012) 0.79
Delayed hemorrhage from hepatic artery after ultrasound-guided percutaneous liver biopsy: a case report. World J Gastroenterol (2006) 0.79
Recurrent gastrointestinal bleeding and hepatic infarction after liver biopsy. World J Gastroenterol (2014) 0.79
Shear wave elastography in the evaluation of rejection or recurrent hepatitis after liver transplantation. Eur Radiol (2013) 0.79
The utility of Xenon-133 liver scan in the diagnosis and management of nonalcoholic fatty liver disease. Can J Gastroenterol (2012) 0.79
Portalsystemic hemodynamic changes in chronic severe hepatitis B: An ultrasonographic study. World J Gastroenterol (2008) 0.78
Non-invasive prediction of forthcoming cirrhosis-related complications. World J Gastroenterol (2014) 0.78
Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective. Int J Hepatol (2015) 0.78
Implementation of a Multicenter Biobanking Collaboration for Next-Generation Sequencing-Based Biomarker Discovery Based on Fresh Frozen Pretreatment Tumor Tissue Biopsies. Oncologist (2016) 0.77
MR Elastography of Liver Disease: State of the Art. Appl Radiol (2013) 0.77
ARFI elastography in patients with chronic autoimmune liver diseases: A preliminary study. J Ultrasound (2012) 0.77
Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study. Medicine (Baltimore) (2016) 0.77
Diagnostic Performance of MR Elastography and Vibration-controlled Transient Elastography in the Detection of Hepatic Fibrosis in Patients with Severe to Morbid Obesity. Radiology (2016) 0.77
Is juvenile liver biopsy unsafe? Putting an end to a common misapprehension. Pediatr Radiol (2009) 0.77
Liver surgery in the presence of cirrhosis or steatosis: Is morbidity increased? Patient Saf Surg (2008) 0.76
Diffusion-weighted MRI for the assessment of liver fibrosis: principles and applications. Biomed Res Int (2015) 0.76
Transient Elastography and Controlled Attenuation Parameter for Diagnosing Liver Fibrosis and Steatosis in Ontario: An Economic Analysis. Ont Health Technol Assess Ser (2015) 0.76
Serum hepatitis B core antibody titer use in screening for significant fibrosis in treatment-naïve patients with chronic hepatitis B. Oncotarget (2016) 0.75
Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients. World J Gastroenterol (2016) 0.75
Safety, Utilization, and Cost of Image-Guided Percutaneous Liver Biopsy Among Cancer Patients. Cancer Invest (2016) 0.75
Audit of percutaneous liver biopsy. Gut (1995) 0.75
Assessment of transient elastography (FibroScan) for diagnosis of fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Caspian J Intern Med (2016) 0.75
New combined parameter of liver and splenic stiffness as determined by elastography in healthy volunteers. Saudi J Gastroenterol (2016) 0.75
Hemobilia and Melena After Liver Biopsy: A Case Report and Review of Literature. Gastroenterology Res (2013) 0.75
Changing Concepts of Cirrhotic Coagulopathy. Am J Gastroenterol (2016) 0.75
Interventional radiology. Application to family practice. Can Fam Physician (1996) 0.75
Percutaneous liver biopsy after living donor liver transplantation resulting in fulminant hepatic failure: the first reported case of hepatic compartment syndrome. J Transplant (2010) 0.75
Emergency right hepatectomy after laparoscopic tru-cut liver biopsy. Int J Surg Case Rep (2015) 0.75
The prevalence of bright liver echo pattern in patients with chronic hepatitis C: correlation with steatosis and fibrosis. J Ultrasound (2014) 0.75
Liver biopsy in liver transplant recipients. Semin Intervent Radiol (2004) 0.75
Successful Hemostasis with Recombinant Activated Factor VII in a Patient with Massive Hepatic Subcapsular Hematoma. Case Rep Gastroenterol (2009) 0.75
Histological Evaluation of Non-alcoholic Fatty Liver Disease and Its Correlation with Different Noninvasive Scoring Systems with Special Reference to Fibrosis: A Single Center Experience. J Clin Exp Hepatol (2016) 0.75
Risk of Bleeding in End-Stage Liver Disease Patients Undergoing Cardiac Catheterization. Tex Heart Inst J (2015) 0.75
Elastography in Chronic Liver Disease: Modalities, Techniques, Limitations, and Future Directions. Radiographics (2016) 0.75
The effect of processing on liver biopsy core size. Dig Dis Sci (2008) 0.75
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51
A clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. N Engl J Med (1998) 5.67
Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84
Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut (1990) 4.60
Simplified assessment of segmental colonic transit. Gastroenterology (1987) 4.59
Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology (1998) 4.52
The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med (1985) 4.30
Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology (1993) 4.23
Surgical management of Meckel's diverticulum. An epidemiologic, population-based study. Ann Surg (1994) 4.16
Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90
Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology (2001) 3.85
Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology (1990) 3.77
The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology (2001) 3.60
A patient questionnaire to identify bowel disease. Ann Intern Med (1989) 3.43
Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med (1996) 3.38
Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34
A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc (1994) 3.14
Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. Radiology (1989) 3.12
Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology (1993) 2.99
Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89
Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut (2000) 2.86
Medical costs in community subjects with irritable bowel syndrome. Gastroenterology (1995) 2.81
Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75
A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease. Am J Gastroenterol (1997) 2.65
The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology (1997) 2.57
Temporal lobe seizures: lateralization with MR volume measurements of the hippocampal formation. Radiology (1990) 2.56
Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol (1992) 2.54
Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology (1978) 2.52
Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35
Sex differences in evaluation and outcome of unstable angina. JAMA (2000) 2.33
Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31
A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol (2000) 2.27
Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med (1982) 2.23
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut (2005) 2.22
Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology (1999) 2.19
The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology (1989) 2.19
Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology (1992) 2.17
Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg (1997) 2.16
Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2015) 2.13
Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology (1994) 2.12
Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterol Motil (2014) 2.11
Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome. Gastroenterology (1990) 2.09
Severe exercise-induced ischemia does not identify high risk patients with normal left ventricular function and one- or two-vessel coronary artery disease. J Am Coll Cardiol (1994) 2.08
Clinical predictors of recurrent Clostridium difficile infection in out-patients. Aliment Pharmacol Ther (2014) 2.08
Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut (2001) 2.05
Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol (1996) 2.01
Self-reported abuse and gastrointestinal disease in outpatients: association with irritable bowel-type symptoms. Am J Gastroenterol (1995) 1.99
Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med (1987) 1.98
Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol (1995) 1.94
Predictors of outcome after percutaneous endoscopic gastrostomy: a community-based study. Mayo Clin Proc (1992) 1.94
Lipoprotein analysis in the evaluation of chest pain in the emergency department. Mayo Clin Proc (1991) 1.92
Effects of an irritable bowel syndrome educational class on health-promoting behaviors and symptoms. Am J Gastroenterol (1998) 1.88
Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl (2000) 1.88
A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2003) 1.85
MR imaging-based volume measurements of the hippocampal formation and anterior temporal lobe: validation studies. Radiology (1990) 1.84
Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut (1988) 1.82
Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci (1995) 1.81
Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol (1985) 1.81
Quality of life after proctocolectomy. A comparison of Brooke ileostomy, Kock pouch, and ileal pouch-anal anastomosis. Gastroenterology (1991) 1.77
Towards a less costly but accurate test of gastric emptying and small bowel transit. Dig Dis Sci (1991) 1.76
Functional constipation and outlet delay: a population-based study. Gastroenterology (1993) 1.74
Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions. Neurogastroenterol Motil (2009) 1.73
Human gastric emptying and colonic filling of solids characterized by a new method. Am J Physiol (1989) 1.73
Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol (2000) 1.71
Increasing incidence of pancreatic cancer among women in Olmsted County, Minnesota, 1940 through 1988. Mayo Clin Proc (1992) 1.69
Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease. Gastroenterology (1990) 1.69
Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther (2011) 1.68
The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient. Liver Transpl Surg (1997) 1.68
Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut (1990) 1.68
Relationship between symptoms and disordered continence mechanisms in women with idiopathic faecal incontinence. Gut (2005) 1.67
Chronic ulcerative colitis: incidence and prevalence in a community. Gut (1987) 1.66
Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. J Infect Dis (2000) 1.66
Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology (2001) 1.64
Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc (2000) 1.64
Modulation of collagen gene expression by cytokines: stimulatory effect of transforming growth factor-beta1, with divergent effects of epidermal growth factor and tumor necrosis factor-alpha on collagen type I and collagen type IV. J Lab Clin Med (1997) 1.64
Impact of endoscopist withdrawal speed on polyp yield: implications for optimal colonoscopy withdrawal time. Aliment Pharmacol Ther (2006) 1.63
Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology (1996) 1.62
Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med (2000) 1.61
Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology (1999) 1.61
A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil (2005) 1.60
Clinical and radiologic features of cerebral edema in fulminant hepatic failure. Mayo Clin Proc (1995) 1.59
Adrenergic modulation of human colonic motor and sensory function. Am J Physiol (1997) 1.59
[13C]octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy. Gastroenterology (1997) 1.59
Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays. J Clin Microbiol (1991) 1.59
A new questionnaire for constipation and faecal incontinence. Aliment Pharmacol Ther (2004) 1.58
Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil (2005) 1.56
Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis. Mayo Clin Proc (1990) 1.56
Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. N Engl J Med (1983) 1.56
Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy. Am J Gastroenterol (2000) 1.56
Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int (1990) 1.55
Liver transplantation for Wilson's disease: a single-center experience. Liver Transpl Surg (1999) 1.55
Determinants of response to a prokinetic agent in neuropathic chronic intestinal motility disorder. Gastroenterology (1994) 1.54
Dual color fluorescence in situ hybridization to investigate aneuploidy in sperm from 33 normal males and a man with a t(2;4;8)(q23;q27;p21) Fertil Steril (1994) 1.54
Utilization and outcomes of surgical gastrostomies and jejunostomies in an era of percutaneous endoscopic gastrostomy: a population-based study. Mayo Clin Proc (1995) 1.54
Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study. Mayo Clin Proc (1992) 1.53
Prospective evaluation of vertical banded gastroplasty as the primary operation for morbid obesity. Mayo Clin Proc (1991) 1.52
Optimizing analysis of stable isotope breath tests to estimate gastric emptying of solids. Neurogastroenterol Motil (2009) 1.51
Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues. Hepatology (1998) 1.49
Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology (1999) 1.49